S&P 500   3,961.34 (-0.41%)
DOW   32,358.83 (-0.23%)
QQQ   305.51 (-1.05%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
S&P 500   3,961.34 (-0.41%)
DOW   32,358.83 (-0.23%)
QQQ   305.51 (-1.05%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
S&P 500   3,961.34 (-0.41%)
DOW   32,358.83 (-0.23%)
QQQ   305.51 (-1.05%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
S&P 500   3,961.34 (-0.41%)
DOW   32,358.83 (-0.23%)
QQQ   305.51 (-1.05%)
AAPL   156.43 (-1.17%)
MSFT   272.99 (-1.23%)
META   199.55 (-1.62%)
GOOGL   100.84 (-1.58%)
AMZN   96.66 (-1.41%)
TSLA   187.21 (-2.40%)
NVDA   262.00 (-1.25%)
NIO   9.16 (+2.58%)
BABA   97.99 (+13.78%)
AMD   93.85 (-2.86%)
T   18.77 (-0.53%)
F   11.56 (+0.35%)
MU   58.77 (-1.71%)
CGC   1.82 (-3.46%)
GE   92.76 (-0.59%)
DIS   94.82 (-0.84%)
AMC   5.35 (+17.58%)
PYPL   72.20 (-1.50%)
PFE   39.90 (-0.80%)
NFLX   323.10 (-1.39%)
NYSE:PJT

PJT Partners - PJT Stock Forecast, Price & News

$73.32
-0.08 (-0.11%)
(As of 03/28/2023 02:46 PM ET)
Add
Compare
Today's Range
$72.47
$73.69
50-Day Range
$72.00
$81.54
52-Week Range
$61.37
$83.17
Volume
137,285 shs
Average Volume
202,681 shs
Market Capitalization
$1.77 billion
P/E Ratio
20.89
Dividend Yield
1.36%
Price Target
$85.00

PJT Partners MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
16.0% Upside
$85.00 Price Target
Short Interest
Healthy
2.47% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$2.40 M Sold Last Quarter
Proj. Earnings Growth
15.38%
From $4.55 to $5.25 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.71 out of 5 stars

Finance Sector

310th out of 891 stocks

Investment Advice Industry

17th out of 48 stocks


PJT stock logo

About PJT Partners (NYSE:PJT) Stock

PJT Partners, Inc. is a holding company, which engages in the provision of advisory-investment solutions. It specializes in strategic advisory, shareholder engagement, restructuring and special situations and private fund advisory and placement services to corporations, financial sponsors, institutional investors, and governments. It operates through International and Domestic segments. The company was founded on November 5, 2014 and is headquartered in New York, NY.

Receive PJT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PJT Partners and its competitors with MarketBeat's FREE daily newsletter.

PJT Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
JMP Securities Reaffirms Their Buy Rating on PJT Partners (PJT)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
PJT Partners declares $0.25 dividend
PJT Partners Earnings Preview
PJT Partners (NYSE: PJT)
See More Headlines
Receive PJT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PJT Partners and its competitors with MarketBeat's FREE daily newsletter.

PJT Company Calendar

Last Earnings
2/07/2023
Ex-Dividend for 3/22 Dividend
3/07/2023
Dividend Payable
3/22/2023
Today
3/28/2023
Next Earnings (Estimated)
4/25/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Investment advice
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
833
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$85.00
High Stock Price Forecast
$86.00
Low Stock Price Forecast
$83.00
Forecasted Upside/Downside
+16.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$164.77 million
Pretax Margin
19.65%

Debt

Sales & Book Value

Annual Sales
$1.03 billion
Cash Flow
$5.18 per share
Book Value
$31.03 per share

Miscellaneous

Free Float
23,305,000
Market Cap
$1.76 billion
Optionable
Optionable
Beta
0.78

Key Executives

  • Paul Jeffrey Taubman
    Chairman & Chief Executive Officer
  • Paige Costigan
    Chief Operating Officer & Partner
  • Helen T. Meates
    Chief Financial & Accounting Officer
  • Ji-Yeun Lee
    Managing Partner
  • Suzanne L. Stefany
    Partner













PJT Stock - Frequently Asked Questions

Should I buy or sell PJT Partners stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PJT Partners in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PJT shares.
View PJT analyst ratings
or view top-rated stocks.

What is PJT Partners' stock price forecast for 2023?

4 brokers have issued twelve-month price targets for PJT Partners' shares. Their PJT share price forecasts range from $83.00 to $86.00. On average, they anticipate the company's share price to reach $85.00 in the next twelve months. This suggests a possible upside of 16.7% from the stock's current price.
View analysts price targets for PJT
or view top-rated stocks among Wall Street analysts.

How have PJT shares performed in 2023?

PJT Partners' stock was trading at $73.69 at the beginning of the year. Since then, PJT stock has decreased by 1.1% and is now trading at $72.86.
View the best growth stocks for 2023 here
.

When is PJT Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our PJT earnings forecast
.

How were PJT Partners' earnings last quarter?

PJT Partners Inc. (NYSE:PJT) released its earnings results on Tuesday, February, 7th. The financial services provider reported $1.08 EPS for the quarter, missing analysts' consensus estimates of $1.21 by $0.13. The financial services provider had revenue of $279.95 million for the quarter, compared to analysts' expectations of $296 million. PJT Partners had a trailing twelve-month return on equity of 20.24% and a net margin of 8.83%.

How often does PJT Partners pay dividends? What is the dividend yield for PJT Partners?

PJT Partners declared a quarterly dividend on Tuesday, February 7th. Investors of record on Wednesday, March 8th will be given a dividend of $0.25 per share on Wednesday, March 22nd. This represents a $1.00 annualized dividend and a dividend yield of 1.37%. The ex-dividend date of this dividend is Tuesday, March 7th.
Read our dividend analysis for PJT
.

Is PJT Partners a good dividend stock?

PJT Partners (NYSE:PJT) pays an annual dividend of $1.00 per share and currently has a dividend yield of 1.39%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 28.49%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PJT will have a dividend payout ratio of 19.05% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PJT.

What other stocks do shareholders of PJT Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PJT Partners investors own include Blackstone (BX), AT&T (T), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Pfizer (PFE), Bank of America (BAC), Walt Disney (DIS), Verizon Communications (VZ), AbbVie (ABBV) and Ford Motor (F).

What is PJT Partners' stock symbol?

PJT Partners trades on the New York Stock Exchange (NYSE) under the ticker symbol "PJT."

Who are PJT Partners' major shareholders?

PJT Partners' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Clearbridge Investments LLC (4.12%), Alliancebernstein L.P. (3.72%), Eagle Asset Management Inc. (3.61%), abrdn plc (2.28%), Geode Capital Management LLC (1.97%) and Dimensional Fund Advisors LP (1.67%). Insiders that own company stock include Grace Reksten Skaugen, Helen T Meates and James W Cuminale.
View institutional ownership trends
.

How do I buy shares of PJT Partners?

Shares of PJT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PJT Partners' stock price today?

One share of PJT stock can currently be purchased for approximately $72.86.

How much money does PJT Partners make?

PJT Partners (NYSE:PJT) has a market capitalization of $1.76 billion and generates $1.03 billion in revenue each year. The financial services provider earns $164.77 million in net income (profit) each year or $3.51 on an earnings per share basis.

How many employees does PJT Partners have?

The company employs 833 workers across the globe.

How can I contact PJT Partners?

PJT Partners' mailing address is 280 PARK AVENUE, NEW YORK NY, 10017. The official website for the company is www.pjtpartners.com. The financial services provider can be reached via phone at (212) 364-7800 or via email at investorrelations@pjtpartners.com.

This page (NYSE:PJT) was last updated on 3/28/2023 by MarketBeat.com Staff